| Accession Number | 0001610717-26-000126 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Clinical Development | Common Stock | โ | Mar 17, 2026 | Sale | 2,010 | $99.48 | $199,955.60 | 116,063 | Direct | โ | View Details |